Dr. Samuel Murray

BSc, MSc, Ph.D. – Chief Scientific Officer & CEO

After majoring in chemistry, biochemistry, immunology, and biology in Australia (BSc + MSc with honors) he obtained his Ph.D. in Biochemistry and Medicine in London at Imperial College / University College London.

Sam has 25+ years’ experience in molecular medicine (clinical and molecular genetics, pathology,biochemistry), more than 50 internationally peer-reviewed publications and over 200 presentations (national/ international); he is also a member of several scientific societies, an editorial board member of several international journals, a regular peer reviewer and a recognized KOL in several fields. His special interests include oncology/hematology biomarkers and companion diagnostic(s) development.

He is a Director of several companies and maintains research and development ties in academia and industry. Sam is also a participant in several independent European committees on EQA, bio-safety & diagnostics. He participates in guidelines committees for oncology and biomarkers and is a SAG member of the EMQN.